👉 Most biotech founders experience that external conversations consume more energy than they should . Investor calls take too long before reaching substance. Partner discussions sound positive but rarely lead to concrete next steps. Business development conversations feel inconsistent, even when the company and the science have not changed. 👉 The natural reaction is to improve communication. Founders refine their pitch, rewrite slides, and rehearse explanations. Yet better